Honorary Chairman, Celltrion Group, South Korea
JungJin SEO knew very little about science before founding what is now a multibillion-dollar global pharmaceutical company: Celltrion. Following the misfortune of losing his job at an automaker, JungJin seized the opportunity to pivot his career when he heard a scientist speak on the future of medicine. Today, Celltrion develops groundbreaking drugs to treat cancer, autoimmune diseases and COVID-19 pandemic.
JungJin led his team to develop biosimilars — affordable biologic products highly similar to approved biological drugs — that yield treatments that mimic the body’s natural antibodies. Celltrion launched its first biosimilar drug, Remsima, for the treatment of autoimmune diseases, followed by drugs for breast cancer and lymphoma that are now used worldwide.
The company led the field in developing an antibody treatment for COVID-19 pandemic, which was approved for use in South Korea in February 2021. Celltrion offers the treatment to Koreans at production cost.
Representing South Korea, JungJin was selected as EY World Entrepreneur Of The Year 2021.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
EY | Assurance | Consulting | Strategy and Transactions | Tax
EY is a global leader in assurance, consulting, strategy and transactions, and tax services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
© EYGM Limited. All Rights Reserved.
This material has been prepared for general informational purposes only and is not intended to be relied upon as accounting, tax, or other professional advice. Please refer to your advisors for specific advice.
In addition to cookies that are strictly necessary to operate this website, we use the following types of cookies to improve your experience and our services: Functional cookies to enhance your experience (e.g. remember settings), and Performance cookies to measure the website's performance and improve your experience., and Marketing/Targeting cookies, which are set by third parties, allow us to execute marketing campaigns, manage our relationship with you, build a profile of your interests and provide you with content or service offerings in accordance with your preferences.
We have detected that Do Not Track/Global Privacy Control is enabled in your browser; as a result, Marketing/Targeting cookies, which are set by third parties that allow us to execute marketing campaigns, manage our relationship with you, build a profile of your interests and provide you with content or service offerings in accordance with your preferences are automatically disabled.
I decline optional cookies